Myrcludex B in Combination With Peginterferon Alfa-2a Versus Peginterferon Alfa-2a Alone in Patients With Chronic Viral Hepatitis B With Delta-agent

Clinical trial NCT02888106 · COMPLETED

Trial details

NCT number: NCT02888106
Sponsor: Hepatera Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Viral Hepatitis B With Delta-agent

Start date: 2016-04-01
Primary completion: 2019-11-22
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.